With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?
While Pfizer's dividend looks like a trap, its strong balance sheet and low valuation make it safer.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.